bacterial infections


Summary: Infections by bacteria, general or unspecified.

Top Publications

  1. Lisher J, Giedroc D. Manganese acquisition and homeostasis at the host-pathogen interface. Front Cell Infect Microbiol. 2013;3:91 pubmed publisher
  2. Behndig A, Cochener B, Güell J, Kodjikian L, Mencucci R, Nuijts R, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421-31 pubmed publisher
    ..Major obstacles include legal barriers or persisting controversy about the scientific rationale for systematic intracameral cefuroxime use in some countries and, until recently, lack of a commercially available preparation...
  3. Nuutila J, Jalava Karvinen P, Hohenthal U, Kotilainen P, Pelliniemi T, Nikoskelainen J, et al. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections. Hum Immunol. 2013;74:522-30 pubmed publisher
    ..In summary, bacterial and viral infections induce different expression patterns of membrane-bound complement regulators in human leukocytes, which may be effectively exploited in clinical differential diagnosis...
  4. Cuenca A, Wynn J, Moldawer L, Levy O. Role of innate immunity in neonatal infection. Am J Perinatol. 2013;30:105-12 pubmed publisher
  5. Gomez B, Bressan S, Mintegi S, Da Dalt L, Blazquez D, Olaciregui I, et al. Diagnostic value of procalcitonin in well-appearing young febrile infants. Pediatrics. 2012;130:815-22 pubmed publisher
    ..Our objective was to assess its performance in diagnosing serious bacterial infections and specifically invasive bacterial infections (IBIs) in well-appearing infants aged <3 months with ..
  6. Liderot K, Ahl M, Ozenci V. Secondary bacterial infections in patients with seasonal influenza A and pandemic H1N1. Biomed Res Int. 2013;2013:376219 pubmed publisher
    The aim of the present study is to analyse the secondary bacterial infections in a large group of patients with seasonal influenza A and influenza A(H1N1) pdm09...
  7. Palmer A, Kishony R. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat Rev Genet. 2013;14:243-8 pubmed publisher tools for studying the evolution of antibiotic resistance and discuss how the genomic and evolutionary insights they provide could transform the diagnosis, treatment and predictability of antibiotic resistance in bacterial infections.
  8. Hombach M, Bottger E, Roos M. The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines. Clin Microbiol Infect. 2013;19:E59-71 pubmed publisher
    ..Laboratories should know their epidemiology settings to be able to detect problems of individual species/drug/clinical breakpoint combinations and take measures to improve precision of diameter measurements...
  9. Taur Y, Pamer E. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis. 2013;26:332-7 pubmed publisher
    ..This article reviews and discusses recent work providing insight into the intestinal microbiota of these at-risk immunocompromised patients...

More Information


  1. Goff D, Jankowski C, Tenover F. Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs. Pharmacotherapy. 2012;32:677-87 pubmed publisher
  2. Shlaes D. New ?-lactam-?-lactamase inhibitor combinations in clinical development. Ann N Y Acad Sci. 2013;1277:105-14 pubmed publisher
    ..Additional novel combinations are in preclinical development. This review will focus on the biochemistry, antimicrobial activity, pharmacodynamics, and clinical development of these novel combinations...
  3. Grant S, Hung D. Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence. 2013;4:273-83 pubmed publisher
    ..The consequences of persistent bacterial infections potentially include increased morbidity and mortality from the infection itself as well as an increased ..
  4. Nijman R, Vergouwe Y, Thompson M, van Veen M, van Meurs A, van der Lei J, et al. Clinical prediction model to aid emergency doctors managing febrile children at risk of serious bacterial infections: diagnostic study. BMJ. 2013;346:f1706 pubmed publisher
    To derive, cross validate, and externally validate a clinical prediction model that assesses the risks of different serious bacterial infections in children with fever at the emergency department.
  5. Arazna M, Pruchniak M, Demkow U. Neutrophil extracellular traps in bacterial infections: strategies for escaping from killing. Respir Physiol Neurobiol. 2013;187:74-7 pubmed publisher
    ..Recently a number of studies highlight the mechanism of bacterial escape from extracellular traps; the process that may influence the outcome of bacterial infections.
  6. Avkan Oguz V, Ozkardesler S, Unek T, Ozbilgin M, Akan M, Firuzan E, et al. Risk factors for early bacterial infections in liver transplantation. Transplant Proc. 2013;45:993-7 pubmed publisher
    ..Our aim was to determine perioperative risk factors for early bacterial infection after liver transplantation...
  7. Derde L, Cooper B, Goossens H, Malhotra Kumar S, Willems R, Gniadkowski M, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14:31-39 pubmed publisher
    ..We assessed interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in European ICUs...
  8. Bunschoten A, Welling M, Termaat M, Sathekge M, van Leeuwen F. Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjug Chem. 2013;24:1971-89 pubmed publisher
    b>Bacterial infections have always been, and still are, a major global healthcare problem. For accurate treatment it is of upmost importance that the location(s), severity, type of bacteria, and therapeutic response can be accurately staged...
  9. Bierne H, Hamon M, Cossart P. Epigenetics and bacterial infections. Cold Spring Harb Perspect Med. 2012;2:a010272 pubmed publisher
    ..Their effects might generate specific, long-lasting imprints on host cells, leading to a memory of infection that influences immunity and might be at the origin of unexplained diseases...
  10. Claude J, Grimm A, Savage H, Pinkerton K. Perinatal exposure to environmental tobacco smoke (ETS) enhances susceptibility to viral and secondary bacterial infections. Int J Environ Res Public Health. 2012;9:3954-64 pubmed publisher
  11. Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis. 2013;13:19 pubmed publisher
    ..In order to assess the adequacy of the empirical therapy, the prevalence and the resistance pattern of the main bacteria responsible for UTI in the community (in Aveiro, Portugal) was evaluated throughout a ten-year period...
  12. Vladimer G, Marty Roix R, Ghosh S, Weng D, Lien E. Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol. 2013;16:23-31 pubmed publisher
    ..Future research will determine how specific inflammasome components pair up in optimal responses to specific bacteria...
  13. Pulcini C, Gyssens I. How to educate prescribers in antimicrobial stewardship practices. Virulence. 2013;4:192-202 pubmed publisher
  14. Sia A, Allred B, Raymond K. Siderocalins: Siderophore binding proteins evolved for primary pathogen host defense. Curr Opin Chem Biol. 2013;17:150-7 pubmed publisher
    ..Additionally, siderocalins have been observed in many roles unrelated to pathogen defense including differentiation, embryogenesis, inflammation, and cancer...
  15. Canton R, Bryan J. Global antimicrobial resistance: from surveillance to stewardship. Part 2: stewardship initiatives. Expert Rev Anti Infect Ther. 2012;10:1375-7 pubmed publisher
    ..The authors also report new data on antibiotic prescribing in primary care and latest research in the development of novel antibiotics for the future...
  16. Ciofu O, Hansen C, Høiby N. Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med. 2013;19:251-8 pubmed publisher
    ..The purpose of this review is to summarize the knowledge on disease and treatment of infection with CF-related pathogens...
  17. Günther G, Dreger B. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections. Microbiol Immunol. 2013;57:527-35 pubmed publisher
    ..tolerance of administering 5% intravenous immunoglobulin, secondary immunodeficiency and recurrent serious bacterial infections. A single center, post-marketing, observational clinical study was performed on 10 patients with a variety ..
  18. Friedrich N, Hagedorn M, Soldati Favre D, Soldati T. Prison break: pathogens' strategies to egress from host cells. Microbiol Mol Biol Rev. 2012;76:707-20 pubmed publisher
    ..This review compares egress strategies of bacteria, pathogenic yeast, and kinetoplastid and apicomplexan parasites. Emphasis is given to recent advances in the biology of egress in mycobacteria and apicomplexans...
  19. Poulikakos P, Falagas M. Aminoglycoside therapy in infectious diseases. Expert Opin Pharmacother. 2013;14:1585-97 pubmed publisher
    ..Aminoglycosides are of the oldest antibiotics. Even though representatives of the class are used in various applications, the use that has established aminoglycosides in medicine is their antimicrobial activity...
  20. Salipante S, Sengupta D, Rosenthal C, COSTA G, Spangler J, Sims E, et al. Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS ONE. 2013;8:e65226 pubmed publisher
    ..The described method is sufficiently rapid (theoretically compatible with same-day turnaround times) and inexpensive for routine clinical use...
  21. Guan X, Xue X, Liu Y, Wang J, Wang Y, Wang J, et al. Plasmid-mediated quinolone resistance--current knowledge and future perspectives. J Int Med Res. 2013;41:20-30 pubmed publisher
    ..Since then, many other genes have been identified and the underlying mechanisms of resistance have been elucidated. This review provides an overview of quinolone resistance, with particular emphasis on plasmid-mediated resistance...
  22. Su D, Zhuo C, Liao K, Cheng W, Cheng H, Zhao X. Value of serum procalcitonin levels in predicting spontaneous bacterial peritonitis. Hepatogastroenterology. 2013;60:641-6 pubmed
    ..We aimed to systemically and quantitatively summarize the current evidence on the diagnostic value of the procalcitonin (PCT) test in identifying SBP...
  23. Liu Z, Petersen R, DEVIREDDY L. Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections. J Immunol. 2013;190:4692-706 pubmed publisher
    ..Neutrophils from SGD patients, who are prone to bacterial infections, lack normal functions, but the potential role of 24p3 in neutrophil dysfunction in SGD is not known...
  24. Troxell B, Hassan H. Transcriptional regulation by Ferric Uptake Regulator (Fur) in pathogenic bacteria. Front Cell Infect Microbiol. 2013;3:59 pubmed publisher
    ..This review focuses on the breadth of Fur regulation in pathogenic bacteria. ..
  25. Neumann S, Krause S, Maschmeyer G, Schiel X, von Lilienfeld Toal M. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncolo. Ann Hematol. 2013;92:433-42 pubmed publisher
    b>Bacterial infections are the most common cause for treatment-related mortality in patients with neutropenia after chemotherapy...
  26. Schuetz P, Muller B, Christ Crain M, Stolz D, Tamm M, Bouadma L, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2012;:CD007498 pubmed publisher
    ..procalcitonin - the prohormone of calcitonin - has emerged as a promising marker for the diagnosis of bacterial infections and for improving decisions about antibiotic therapy...
  27. Worthington R, Melander C. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol. 2013;31:177-84 pubmed publisher
    ..we describe recent developments toward combination therapies for the treatment of multidrug-resistant bacterial infections. These efforts include antibiotic-antibiotic combinations, and the development of adjuvants that either ..
  28. Kastenmüller W, Torabi Parizi P, Subramanian N, Lämmermann T, Germain R. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell. 2012;150:1235-48 pubmed publisher
  29. Laxminarayan R, Duse A, Wattal C, Zaidi A, Wertheim H, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057-98 pubmed publisher
    ..which we today take for granted, would not be possible without access to effective treatment for bacterial infections. Within just a few years, we might be faced with dire setbacks, medically, socially, and economically, ..
  30. Wintermans B, Reuland E, Wintermans R, Bergmans A, Kluytmans J. The cost-effectiveness of ESBL detection: towards molecular detection methods?. Clin Microbiol Infect. 2013;19:662-5 pubmed publisher
    ..Using Etest to detect the presence of ESBL results in a false-positive outcome in 14% of the cases. This results in unnecessary isolation of patients, which can be omitted by using a genotypic method...
  31. Pendleton J, Gorman S, Gilmore B. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11:297-308 pubmed publisher
  32. De S, Williams G, Hayen A, Macaskill P, McCaskill M, Isaacs D, et al. Accuracy of the "traffic light" clinical decision rule for serious bacterial infections in young children with fever: a retrospective cohort study. BMJ. 2013;346:f866 pubmed publisher
    ..traffic light system developed by the National Institute for Health and Clinical Excellence (NICE)) for detecting three common serious bacterial infections (urinary tract infection, pneumonia, and bacteraemia) in young febrile children.
  33. Falagas M, Tansarli G, Ikawa K, Vardakas K. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis. 2013;56:272-82 pubmed publisher
    ..Well-designed randomized controlled trials are warranted to confirm these findings before such approaches become widely used...
  34. Wilson D. Insights from genomics into bacterial pathogen populations. PLoS Pathog. 2012;8:e1002874 pubmed publisher
    ..The purpose of this review is to highlight the transformative effect of population genomics on bacteriology, and to consider the prospects for answering abiding questions such as why bacteria cause disease...
  35. Gomes J, Grunau A, Lawrence A, Eberl L, Gademann K. Bioinspired surfaces against bacterial infections. Chimia (Aarau). 2013;67:275-8 pubmed
    Bioactive surfaces that can prevent bacterial infections are of great interest since device-related infections represent an emerging and major threat to our health-care system...
  36. Stedtfeld R, Williams M, Fakher U, Johnson T, Stedtfeld T, Wang F, et al. Antimicrobial resistance dashboard application for mapping environmental occurrence and resistant pathogens. FEMS Microbiol Ecol. 2016;92: pubmed publisher
    ..Interested users are invited to download a beta version (available on iOS or Android), submit AR information using the application, and provide feedback on current and prospective functionalities. ..
  37. Yang H, Wang W, Tan Y, Zhang D, Wu J, Lei X. Investigation and analysis of the characteristics and drug sensitivity of bacteria in skin ulcer infections. Chin J Traumatol. 2017;20:194-197 pubmed publisher
    ..aeruginosa becomes the most important skin infection pathogen. These characteristics of bacterial infections of skin ulcers provide a significant reference for guiding the selection of antibiotics, better controlling ..
  38. Negash K, Andonian C, Felgate C, Chen C, Goljer I, Squillaci B, et al. The metabolism and disposition of GSK2140944 in healthy human subjects. Xenobiotica. 2016;46:683-702 pubmed publisher
    1. GSK2140944 is a novel bacterial topoisomerase inhibitor in development for the treatment of bacterial infections. The metabolism and disposition in healthy human subjects was investigated. 2...
  39. Costa S, Barioni E, Ignacio A, Albuquerque J, Camara N, Pavani C, et al. Beneficial effects of Red Light-Emitting Diode treatment in experimental model of acute lung injury induced by sepsis. Sci Rep. 2017;7:12670 pubmed publisher
    ..our data has shown the beneficial effects of short treatment with LED on ALI that are caused by gram negative bacterial infections. It is suggested that LED applications are an inexpensive and non-invasive additional treatment for sepsis.
  40. Voukeng I, Beng V, Kuete V. Antibacterial activity of six medicinal Cameroonian plants against Gram-positive and Gram-negative multidrug resistant phenotypes. BMC Complement Altern Med. 2016;16:388 pubmed
    ..The tested plants could be a reservoir of molecules to fight against MDR bacterial infections.
  41. van Daalen F, Geerlings S, Prins J, Hulscher M. A survey to identify barriers of implementing an antibiotic checklist. Eur J Clin Microbiol Infect Dis. 2016;35:545-53 pubmed publisher
    ..These insights can be used to improve the specific content of the checklist and to develop an implementation strategy that addresses the identified barriers. ..
  42. Baratali L, Lang P. [Pneumococcal infections: Appraisal and perspectives in terms of adult vaccination]. Presse Med. 2015;44:1155-61 pubmed publisher
    Pneumococcal diseases are the first cause of bacterial infections in adult and in the aged adult...
  43. Rovida F, Piralla A, Marzani F, Moreno A, Campanini G, Mojoli F, et al. Swine influenza A (H1N1) virus (SIV) infection requiring extracorporeal life support in an immunocompetent adult patient with indirect exposure to pigs, Italy, October 2016. Euro Surveill. 2017;22: pubmed publisher
    ..The sole risk factor for influenza was a body mass index?>?30 kg/m2. After a month of hospitalisation, the patient was discharged in good health. ..
  44. Matzneller P, Burian A, Zeitlinger M, Sauermann R. Understanding the Activity of Antibiotics in Cerebrospinal Fluid in vitro. Pharmacology. 2016;97:233-44 pubmed publisher
    ..Methodological recommendations derived from the collected studies are summarized in order to optimize future research on the topic. ..
  45. Laxminarayan R, Amabile Cuevas C, Cars O, Evans T, Heymann D, Hoffman S, et al. UN High-Level Meeting on antimicrobials--what do we need?. Lancet. 2016;388:218-20 pubmed publisher
  46. Qi Z, Ren S, Zhang Q, Zou J, Xu Q, Wang Z, et al. Functional characterization of a short peptidoglycan recognition protein from Chinese giant salamander (Andrias davidianus). Oncotarget. 2017;8:99323-99335 pubmed publisher
    ..proteins (PGRPs) are important pattern recognition receptors (PRRs) involved in immune defense against bacterial infections. In this study, a short PGRP (termed AdPGRP-S1) was cloned and functionally characterized from Chinese ..
  47. Arciniegas Ruiz S, Gutiérrez Olvera L, Bernad Bernad M, Caballero Chacón S, Vargas Estrada D. Comparative pharmacokinetics of a new oral long-acting formulation of doxycycline hyclate: A canine clinical trial. Eur J Pharm Sci. 2015;80:9-15 pubmed publisher
    Doxycicline is used in dogs as treatment of several bacterial infections, mycoplasma, chlamydia and rickettsial diseases. However, it requires long treatments and several doses to be effective...
  48. Lovera R, Fernández M, Jacob J, Lucero N, Morici G, Brihuega B, et al. Intrinsic and extrinsic factors related to pathogen infection in wild small mammals in intensive milk cattle and swine production systems. PLoS Negl Trop Dis. 2017;11:e0005722 pubmed publisher
    ..Hence, we recommend preventing and controlling murines in farm dwellings and isolating farms from their surroundings to avoid contact with other wild mammals. ..
  49. Heinbockel L, Sánchez Gómez S, Martinez de Tejada G, Domming S, Brandenburg J, Kaconis Y, et al. Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors. Antimicrob Agents Chemother. 2013;57:1480-7 pubmed publisher
    b>Bacterial infections are known to cause severe health-threatening conditions, including sepsis...
  50. Lippi G, Sanchis Gomar F. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities. World J Gastroenterol. 2017;23:8283-8290 pubmed publisher
    ..of procalcitonin has recently become a mainstay for the diagnosis and therapeutic management of severe bacterial infections, especially those sustained by Gram-negative bacteria...
  51. Johnson W, France D, Rentz N, Cordell W, Walls F. Sensing bacterial vibrations and early response to antibiotics with phase noise of a resonant crystal. Sci Rep. 2017;7:12138 pubmed publisher
    ..AST) is intrinsically limited by observation of cell colony growth, which can extend over days and allow bacterial infections to advance before effective antibiotics are identified...
  52. Otero C, Díaz D, Uriarte I, Bezrodnik L, Finiasz M, Fink S. Peripheral blood monocyte and T cell subsets in children with specific polysaccharide antibody deficiency (SPAD). Hum Immunol. 2016;77:12-9 pubmed publisher
    ..The clinical presentation of these patients involves recurrent bacterial infections, being the most frequent agent Streptococcus (S.) pneumoniae...
  53. Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, et al. Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT. Bone Marrow Transplant. 2017;52:252-257 pubmed publisher
    ..55; P=0.093 for ?4.0?mg/kg group). Higher dose of thymoglobulin was associated with a higher incidence of bacterial infections, CMV antigenemia and any additional infection...
  54. Swearingen M, Granger J, Sullivan A, Stoodley P. Elution of antibiotics from poly(methyl methacrylate) bone cement after extended implantation does not necessarily clear the infection despite susceptibility of the clinical isolates. Pathog Dis. 2016;74:ftv103 pubmed publisher
    ..However, the TA infection only resolved after multiple rounds of debridement, IV vancomycin and removal of the PMMA beads and placement of vancomycin and tobramycin loaded calcium sulfate beads. ..
  55. Tegou E, Magana M, Katsogridaki A, Ioannidis A, Raptis V, Jordan S, et al. Terms of endearment: Bacteria meet graphene nanosurfaces. Biomaterials. 2016;89:38-55 pubmed publisher
  56. Ju F, Li B, Ma L, Wang Y, Huang D, Zhang T. Antibiotic resistance genes and human bacterial pathogens: Co-occurrence, removal, and enrichment in municipal sewage sludge digesters. Water Res. 2016;91:1-10 pubmed publisher
  57. Chiu S, Shao P, Wang J, Hsu H, Lin M, Chang L, et al. Low immunoglobulin M memory B-cell percentage in patients with heterotaxy syndrome correlates with the risk of severe bacterial infection. Pediatr Res. 2016;79:271-7 pubmed publisher
    ..028). The memory B cell and IgM memory B-cell percentages are low in patients with heterotaxy syndrome, and the presence of IgM memory B-cell percentage < 1% correlates with community-acquired SBI. ..
  58. Lv W, Lu D, He Y, Xiao J, Zhou C, Cheng D. Liver Abscess Formation Following Transarterial Chemoembolization: Clinical Features, Risk Factors, Bacteria Spectrum, and Percutaneous Catheter Drainage. Medicine (Baltimore). 2016;95:e3503 pubmed publisher
    ..Bacterial culture and antibiotic sensitivity tests on pus and blood help on the antibiotics selection. PCD combined with aggressive antibiotics can be recommended as the first-line therapeutic regimen. ..
  59. Nishida S, Ono Y, Sekimizu K. Lactic acid bacteria activating innate immunity improve survival in bacterial infection model of silkworm. Drug Discov Ther. 2016;10:49-56 pubmed publisher
    ..These data suggest that Lactococcus lactis 11/19-B1 would be expected to be useful for making yogurt and probiotics to activate innate immunity. ..
  60. Ragland S, Criss A. From bacterial killing to immune modulation: Recent insights into the functions of lysozyme. PLoS Pathog. 2017;13:e1006512 pubmed publisher
  61. Cai G, Ziko I, Barwood J, Soch A, Sominsky L, Molero J, et al. Overfeeding during a critical postnatal period exacerbates hypothalamic-pituitary-adrenal axis responses to immune challenge: a role for adrenal melanocortin 2 receptors. Sci Rep. 2016;6:21097 pubmed publisher
    ..These data suggest neonatal diet affects the efficiency of the adrenally-mediated response to LPS, potentially influencing how neonatally overfed rats combat bacterial infection. ..
  62. Palamara J, Bonczynski J, Berg J, Bergman P. Perioperative Cefovecin to Reduce the Incidence of Urinary Tract Infection in Dogs Undergoing Hemilaminectomy. J Am Anim Hosp Assoc. 2016;52:297-304 pubmed publisher
    ..This study reemphasizes the importance of continued surveillance for UTIs in patients with prolonged neurologic recovery. ..
  63. Zhang M, Kong X, Zheng J, Wan J, Wang Y, Hu Y, et al. Research and development of antibiotics: insights from patents and citation network. Expert Opin Ther Pat. 2016;26:617-27 pubmed publisher
    ..In this context, systematic understanding of the technology landscape and evolving process of antibiotic R&D may help to provide insights for discovering future antibiotics more rationally...
  64. İlem Özdemir D, Asikoglu M, Ozkilic H, Yilmaz F, Hosgor Limoncu M, Ayhan S. Gamma scintigraphy and biodistribution of (99m)Tc-cefotaxime sodium in preclinical models of bacterial infection and sterile inflammation. J Labelled Comp Radiopharm. 2016;59:109-16 pubmed publisher
    ..The bacterial infection and sterile inflammation imaging capacity of (99m)Tc-CEF was evaluated. Based on the in vivo studies, (99m)Tc-CEF has higher uptake in infected and inflamed thigh muscle than healthy thigh muscle...
  65. Zuccaro L, Cox A, Pray C, Radford K, Novakowski K, Dorrington M, et al. Histone deacetylase activity and recurrent bacterial bronchitis in severe eosinophilic asthma. Allergy. 2016;71:571-5 pubmed publisher
  66. Deak D, Outterson K, Powers J, Kesselheim A. Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015. Ann Intern Med. 2016;165:363-72 pubmed publisher
    ..S. prices for each new antibiotic were obtained from public sources. Recently marketed antibiotics are more expensive but have been approved without evidence of clinical superiority. ..
  67. García Quintanilla M, Pulido M, Carretero Ledesma M, McConnell M. Vaccines for Antibiotic-Resistant Bacteria: Possibility or Pipe Dream?. Trends Pharmacol Sci. 2016;37:143-52 pubmed publisher
  68. Gao K, Lai Y, Huang J, Wang Y, Wang X, Che G. [Preoperatiove Airway Bacterial Colonization: the Missing Link between Non-small Cell Lung Cancer Following Lobectomy and Postoperative Pneumonia?]. Zhongguo Fei Ai Za Zhi. 2017;20:239-247 pubmed publisher
  69. Sampane Donkor E, Badoe E, Annan J, Nii Trebi N. Colonisation of antibiotic resistant bacteria in a cohort of HIV infected children in Ghana. Pan Afr Med J. 2017;26:60 pubmed publisher
    ..aureus and S. pneumoniae. Infections arising in these patients that are caused by S. aureus and S. pneumoniae could be treated with ceftriaxone and cefoxitin respectively...
  70. Saraya T, Kimura H, Kurai D, Ishii H, Takizawa H. The molecular epidemiology of respiratory viruses associated with asthma attacks: A single-center observational study in Japan. Medicine (Baltimore). 2017;96:e8204 pubmed publisher
  71. Lu H, Liu Y, Guo J, Wu H, Wang J, Wu G. Biomaterials with Antibacterial and Osteoinductive Properties to Repair Infected Bone Defects. Int J Mol Sci. 2016;17:334 pubmed publisher
    ..In this review, we will summarize the current knowledge of novel biomaterials with both antibacterial and osteoinductive properties. ..